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An otherwise healthy 64-year-old man with recently diagnosed multiple myeloma was admitted 
to hospital with hypercalcemia and renal failure. Despite his electrocardiogram showing short 
QT/QTc intervals, he was admitted without cardiac monitoring. He died suddenly a few hours 
later, likely from a fatal arrhythmia. This case illustrates that pronounced QT shortening from 
hypercalcemia is an underappreciated malignant finding that can portend a significant risk for 
arrhythmia and sudden cardiac death.  In addition, we also discuss the causes of hypercalcemia 















Although hypocalcaemia is a well-recognised cause of QT prolongation via prolongation of the 
plateau phase of the cardiac action potential, there is much less knowledge about hypercalcemia 
causing short QT. We present an unusual case of hypercalcemia causing short QT. 
 
Case Presentation 
An otherwise healthy 64-year-old man with recently diagnosed multiple myeloma was admitted 
to hospital with confusion, pain over his right fifth rib, and hyperreflexia. He was not known to 
have any structural heart disease or family history of syncope or sudden cardiac death. 
Investigations were notable for hypercalcemia and renal failure: Na 161 mEq/L (normal 135-
145 mEq/L), K 4.9 mEq/L (normal 3.5-5.0 mEq/L), creatinine 292 umol/L (normal 60-110 
umol/L), Ca 4.89 mmol/L (normal 2.2-2.7 mmol/L), albumin 40 g/L (normal 35-55 g/L), CK-
MB 49.74 ng/mL (normal ≤7.7 ng/mL), and troponin 0.069 (normal <0.04). His 
electrocardiogram showed extremely short QT/QTc intervals of 300 ms measured manually 
using the tangent method at a heart rate of 60 beats per minute (Figure 1). His chest X-ray 
demonstrated multiple lytic lesions. The remainder of his investigations were unremarkable. He 
was admitted to a ward bed without cardiac monitoring and initiated on intravenous fluids. He 
died suddenly a few hours later, unwitnessed.  
 
Discussion 
Some “take-home” messages can be derived from this tragic case. Whereas there have been 
several reports of hypercalcemia-induced ventricular tachycardia in patients with primary 
hyperparathyroidism1, this has never previously been described before with multiple myeloma. 
Multiple myeloma is a clonal neoplasm of plasma cells and the second most common adult 
hematologic malignancy. It causes hypercalcemia by secreting osteoclast activating factor, such 
as tumor necrosis factor-beta, interleukin-6, and receptor activator of nuclear factor kappa B 
ligand, which lead to bone resorption and release of calcium into the extracellular fluid. 
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Hypercalcemia is a frequent acquired cause of QT shortening, which is postulated to be due to a 
shortening of phase 2 of the action potential secondary to a decrease in Ca2+ current and increase 
in calcium-activated Cl- current2. On the electrocardiogram, this translates into a shortening of 
the QT interval, primarily through shortening or absence of the ST segment within the QT 
interval. This in turns leads to an abbreviated ventricular refractory period, which is believed to 
predispose individuals to ventricular arrhythmias, in particular ventricular fibrillation and 
sudden cardiac death.3 Although there is an overlap between normal and pathologically short 
QT, like long QT, the arrhythmic risk of short QT rises exponentially with more extreme 
values.3 Thereby in our patient, it is plausible that the extreme hypercalcemia led to a 
pathologically short refractory period which increased the patient’s vulnerability to a fatal 
arrhythmia and ultimately led to his sudden death overnight.  In addition to short QT, several 
other ECG findings – some of which were also present in our patient – have been reported with 
hypercalcemia and are listed in Table 1. Apart from multiple myeloma, causes of hypercalcemia 
include other malignancies, primary and tertiary hyperparathyroidism, hypercalcemia of 
granulomatous disease, acute and chronic renal failure and medications such as thiazide 
diuretics, lithium, and vitamin D.   
 
Conclusion 
Pronounced QT interval shortening with shortening or absence of the ST segment is an 
underappreciated malignant finding that can portend a significant risk for arrhythmia and 
sudden cardiac death. Reports on multiple myeloma causing hypercalcemia-associated short QT 
have not been frequently published before. A change in our clinical practice regarding short QT 
should be considered. Monitoring patients vigilantly while investigating and reversing potential 
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Figure 1: ECG analysis: Sinus rhythm, HR 60 bpm, J-point elevation in V4, V5, I, and aVL, 
almost non-existent ST segment, extremely short QT/QTc (300 ms).  
 
 






Table 1  
ECG characteristic of hypercalcemia  
Sinus 
Rate 
Symptomatic sinus node dysfunction is occasionally observed.4 
PR 
interval 
At very high ionized serum calcium levels, there can be slight PR prolongation.6  
ST 
segment 
The ST segment is usually absent or almost absent, but if it is present, it can be depressed or 
elevated mimicking acute myocardial infarction.5 Prominent J point level elevation has been 
noted and termed "normothermic" Osborn wave.6 
T wave The T wave can become flattened or inverted, biphasic, or notched with a marked decrease in 
amplitude.7 
QT   The QT interval is often shortened. The corrected QT intervals (QTc) can be used as 
indicators of clinical hypercalcemia. 
 
